Full Text View
Tabular View
No Study Results Posted
Related Studies
Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
This study has been completed.
Study NCT00135993   Information provided by UCB, Inc.

First Received on August 24, 2005.   Last Updated on September 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Restless Legs Syndrome
Additional conditions recognized in this trial
Psychomotor Agitation
More general conditions related to this trial
Dyskinesias
Dyssomnias
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Parasomnias
Psychomotor Disorders
Signs and Symptoms
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
Rotigotine
Additional drug interventions recognized in this trial
N 0437
More general drug interventions related to this trial
Dopamine Agents
Dopamine Agonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
UCB, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services